Literature DB >> 27347775

Hepatitis B virus: is a cure possible?

Mirjam B Zeisel1,2, Thomas F Baumert1,2,3.   

Abstract

Entities:  

Keywords:  Hepatitis B virus; hepatocellular carcinoma; liver disease; viral cure

Mesh：

Substances：

Year:  2016        PMID： 27347775      PMCID： PMC7613416          DOI： 10.1080/17512433.2016.1206466

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN： 1751-2433            Impact factor:   4.108


× No keyword cloud information.
  20 in total

1.  Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.

Authors:  Gregor Ebert; Cody Allison; Simon Preston; James Cooney; Jesse G Toe; Michael D Stutz; Samar Ojaimi; Nikola Baschuk; Ueli Nachbur; Joseph Torresi; John Silke; C Glenn Begley; Marc Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

Review 2.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

Review 3.  HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.

Authors:  Michael Nassal
Journal:  Gut       Date:  2015-06-05       Impact factor: 23.059

Review 4.  Mechanisms of HBV-induced hepatocellular carcinoma.

Authors:  Massimo Levrero; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

Review 5.  New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.

Authors:  David Durantel; Fabien Zoulim
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

Review 6.  Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

Authors:  Mirjam B Zeisel; Julie Lucifora; William S Mason; Camille Sureau; Jürgen Beck; Massimo Levrero; Michael Kann; Percy A Knolle; Monsef Benkirane; David Durantel; Marie-Louise Michel; Brigitte Autran; François-Loïc Cosset; Hélène Strick-Marchand; Christian Trépo; Jia-Horng Kao; Fabrice Carrat; Karine Lacombe; Raymond F Schinazi; Françoise Barré-Sinoussi; Jean-François Delfraissy; Fabien Zoulim
Journal:  Gut       Date:  2015-02-10       Impact factor: 23.059

7.  First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.

Authors:  Antje Blank; Christoph Markert; Nicolas Hohmann; Alexandra Carls; Gerd Mikus; Thorsten Lehr; Alexander Alexandrov; Mathias Haag; Matthias Schwab; Stephan Urban; Walter E Haefeli
Journal:  J Hepatol       Date:  2016-04-27       Impact factor: 25.083

8.  Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

Authors:  Pavel Bogomolov; Alexander Alexandrov; Natalia Voronkova; Maria Macievich; Ksenia Kokina; Maria Petrachenkova; Thorsten Lehr; Florian A Lempp; Heiner Wedemeyer; Mathias Haag; Matthias Schwab; Walter E Haefeli; Antje Blank; Stephan Urban
Journal:  J Hepatol       Date:  2016-04-27       Impact factor: 25.083

9.  Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.

Authors:  Carolina Boni; Diletta Laccabue; Pietro Lampertico; Tiziana Giuberti; Mauro Viganò; Simona Schivazappa; Arianna Alfieri; Marco Pesci; Giovanni B Gaeta; Giuseppina Brancaccio; Massimo Colombo; Gabriele Missale; Carlo Ferrari
Journal:  Gastroenterology       Date:  2012-07-14       Impact factor: 22.682

10.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Authors:  Huan Yan; Guocai Zhong; Guangwei Xu; Wenhui He; Zhiyi Jing; Zhenchao Gao; Yi Huang; Yonghe Qi; Bo Peng; Haimin Wang; Liran Fu; Mei Song; Pan Chen; Wenqing Gao; Bijie Ren; Yinyan Sun; Tao Cai; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal:  Elife       Date:  2012-11-13       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.